Outcomes after acute coronary syndrome in patients with inflammatory bowel disease.

Batric PopovicJeanne VarlotJoseph HennequinPierre Adrien MetzdorfNicolas JayEdoardo CamenzindAurélie Bannay

Published in: Heart and vessels (2022)

Our findings suggest that both residual MI risk and bleeding events should be carefully monitored in MI patients diagnosed with chronic inflammation such as that observed in IBD.

Keyphrases

acute coronary syndrome
patients with inflammatory bowel disease
end stage renal disease
newly diagnosed
chronic kidney disease
oxidative stress
prognostic factors
peritoneal dialysis
percutaneous coronary intervention
antiplatelet therapy
patient reported